Severe thrombophilia with antiphospholipid syndrome and hyperhomocysteinemia in a patient with Schnitzler's syndrome

Clinical and Experimental Rheumatology

Volumn 21, Issue 3, 2003, Pages 366-368

  Famularo, Giuseppe ^a   Barracchini, A ^a   Minisola, G ^a  

^a SAN CAMILLO FORLANINI HOSPITAL   (Italy)

Author keywords

Antiphospholipid syndrome; Hyperhomocysteinemia; Schnitzler's syndrome; Thrombophilia

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; ATENOLOL; COLCHICINE; CYCLOSPORIN; DEXCHLORPHENIRAMINE; DOPAMINE; ENOXAPARIN; FOLIC ACID; FUROSEMIDE; GLYCERYL TRINITRATE; HOMOCYSTEINE; HYDROXYZINE; IBUPROFEN; IMMUNOGLOBULIN M; LORATADINE; LOSARTAN; METHYLPREDNISOLONE; METOPROLOL; PREDNISONE; PROTON PUMP INHIBITOR; TERFENADINE; VITAMIN B GROUP; WARFARIN;

ADULT; AMINO ACID BLOOD LEVEL; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD CLOTTING DISORDER; BONE PAIN; CASE REPORT; CAUSE OF DEATH; CLINICAL FEATURE; CORONARY ARTERY THROMBOSIS; DETERIORATION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; FATALITY; HUMAN; HYPERHOMOCYSTEINEMIA; IMMUNE MEDIATED INJURY; LABORATORY TEST; MALE; METABOLIC DISORDER; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE ORGAN FAILURE; OCCLUSIVE CEREBROVASCULAR DISEASE; OUTCOMES RESEARCH; PRIORITY JOURNAL; SCHNITZLER SYNDROME; THROMBOPHILIA; TOTAL PARENTERAL NUTRITION; VITAMIN SUPPLEMENTATION;

ANTIPHOSPHOLIPID SYNDROME; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FATAL OUTCOME; HUMANS; HYPERHOMOCYSTEINEMIA; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; RISK ASSESSMENT; SCHNITZLER SYNDROME; SEVERITY OF ILLNESS INDEX; THROMBOPHILIA;

EID: 0038209740     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. LIPSKER D, VERAN Y, GRUNENBERGER F, CRIBIER B, HEID E, GROSSHANS E: The Schnitzler's syndrome. Four new cases and review of the literature. Medicine (Baltimore) 2001; 80: 37-44.
2. SCHNITZLER L, SCHUBERT B, BOASSON M: Urticaire chronique, lésions osseuses, macroglobulinémie IgM: Maladie de Waldenström? Bull Soc Franc Derm Syph 1974; 81: 363.
3. RYBOJAD M, MORAILLON I, CORDOLIANI F et al.: Syndrome de Schnitzler's avec deficit genetique en C4: Deux observations. Ann Dermatol Venereol 1993; 120: 783-5.
4. PASCUAL-LOPEZ M, HERNANDEZ-NUNEZ A, SANCHEZ-PEREZ J, FERNANDEZ-HERRERA J, GARCIA-DIEZ A: Schnitzler's syndrome with monoclonal IgG kappa gammopathy: Good response to cyclosporin. J Eur Acad Dermatol Venereol 2002; 16: 267-70.
5. SCHARTZ NE, BUDER S, SPERL H et al.: Report of a case of Schnitzler's syndrome treated successfully with interferon alpha 2b. Dermatology 2002; 205: 54-6.
6. WILSON WA, GHARAVI AE, KOIKE M et al.: International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum 1999; 42: 1309-11.
7. GREAVES M: Antiphospholipid antibodies and thrombosis. Lancet 1999; 353: 1348-53.
8. LEVINE JS, BRANCH DW, RAUCH J: The antiphospholipid syndrome. N Engl J Med 2002; 346: 752-63.
9. HANKEY GJ, EIKELBOOM JW: Homocysteine and vascular disease. Lancet 1999; 354: 407-13.